Description
For screening a variety of antiviral-associated compounds; contains >410 antiviral-associated compounds in a 96-well Matrix™ tube rack format as 10 mM stock solutions in DMSO; includes a variety of compounds with antiviral activity against HIV, HBV, HCV, influenza, HSV, and coronaviruses, among others, as well as several compounds with antimalarial activity; molecular targets include HIV reverse transcriptase, protease, and integrase, RNA-dependent RNA polymerases, and HCV NS proteins